ScholarIQanswers from OpenAlex & ORCID
Cristina R. Ferrone
ResearcherPublications, citations & collaboration network
Cristina R. Ferrone is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Cristina R. Ferrone have?
ScholarIQindexed works
Cristina R. Ferrone has 747 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Cristina R. Ferrone have?
ScholarIQcitation count
Cristina R. Ferrone has 27,661 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Cristina R. Ferrone?
ScholarIQh-index
Cristina R. Ferrone has an h-index of 80 in OpenAlex.
What is the i10-index of Cristina R. Ferrone?
ScholarIQi10-index
Cristina R. Ferrone has an i10-index of 244 in OpenAlex.
What is the ORCID of Cristina R. Ferrone?
ScholarIQorcid
The ORCID for Cristina R. Ferrone is on the source record.
What is the OpenAlex record for Cristina R. Ferrone?
ScholarIQopenalex
The OpenAlex for Cristina R. Ferrone is on the source record.
What are the most-cited papers on Cristina R. Ferrone?
ScholarIQmost cited works
Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
Mechteld C. de Jong, Hari Nathan, Georgios C. Sotiropoulos, Andreas Paul, Sorin Alexandrescu, Hugo P. Marques, Carlo Pulitanò, Eduardo Barroso, Bryan M. Clary, Luca Aldrighetti, Cristina R. Ferrone, Andrew X. Zhu, Todd W. Bauer, Dustin M. Walters, T. Clark Gamblin, Kevin T. Nguyen, Ryan S. Turley, Irinel Popescu, Catherine Hubert, Stephanie Meyer, Richard D. Schulick, Michael A. Choti, J. F. Gigot, Gilles Mentha, Timothy M. Pawlik
Perioperative CA19-9 Levels Can Predict Stage and Survival in Patients With Resectable Pancreatic Adenocarcinoma
Cristina R. Ferrone, Dianne M. Finkelstein, Sarah P. Thayer, Alona Muzikansky, Carlos Fernández‐del Castillo, Andrew L. Warshaw
Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma
Peter J. Allen, Deborah Kuk, Carlos Fernández-del Castillo, Olca Baştürk, Christopher L. Wolfgang, John L. Cameron, Keith D. Lillemoe, Cristina R. Ferrone, Vicente Morales‐Oyarvide, Jin He, Matthew J. Weiss, Ralph H. Hruban, Mithat Gönen, David S. Klimstra, Mari Mino–Kenudson
Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
João Incio, Hao Liu, Priya Suboj, Shan M. Chin, Ivy X. Chen, Matthias Pinter, Mei Rosa Ng, Hadi T. Nia, Jelena Grahovac, Shannon Kao, Suboj Babykutty, Yuhui Huang, Keehoon Jung, Nuh N. Rahbari, Xiaoxing Han, Vikash P. Chauhan, John D. Martin, Julia Kahn, Peigen Huang, Vikram Desphande, James Michaelson, Theodoros Michelakos, Cristina R. Ferrone, Raquel Soares, Yves Boucher, Dai Fukumura, Rakesh K. Jain
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Aparna R. Parikh, Emily E. Van Seventer, Giulia Siravegna, Anna Hartwig, Ariel Jaimovich, Yupeng He, Katie Kanter, Madeleine G. Fish, Kathryn Fosbenner, Benchun Miao, Susannah Phillips, John H. Carmichael, Nihaarika Sharma, Joy X. Jarnagin, Islam Baiev, Yojan S. Shah, Isobel J. Fetter, Heather A. Shahzade, Jill N. Allen, Lawrence S. Blaszkowsky, Jeffrey W. Clark, Jon S. Dubois, Joseph W. Franses, Bruce J. Giantonio, Lipika Goyal, Samuel J. Klempner, Ryan David Nipp, Eric Roeland, David P. Ryan, Colin D. Weekes, Jennifer Y. Wo, Theodore S. Hong, Liliana Bordeianou, Cristina R. Ferrone, Motaz Qadan, Hiroko Kunitake, David L. Berger, Rocco Ricciardi, James C. Cusack, Victoria M. Raymond, AmirAli Talasaz, Genevieve M. Boland, Ryan B. Corcoran